亚太地区放射性药物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断核医学和治疗核医学）、应用（肿瘤学、心脏病学、神经学等）和最终用户（医院、影像中心、学术和医院）研究中心等）

市场介绍

亚太地区由中国、日本、印度、澳大利亚和韩国五个主要国家组成。还对亚太地区其他国家的市场进行了评估。日本在预测期内引领市场。近年来，日本不断加大对核医学领域的重视。日本已进入老年人口增长最快的时代；人口老龄化的加剧导致医疗系统的转型。例如，根据世界经济论坛的数据，目前日本70多岁的人口有23亿。该国的卫生转型已取得进展，并对其卫生系统的可持续性造成越来越大的压力。老年人口的增加导致该地区疾病负担增加。政府组织和研究机构参与放射性药物的制造。例如，国立放射线科学研究所所属的放射性药物开发部旨在开发用于临床诊断和治疗的放射性药物、开发合成药物所需的新放射性核素以及制造标记技术。新兴国家的飙升和核医学在个性化治疗中的使用不断增加是推动亚太地区放射性药物市场增长的主要因素。

在COVID-19的情况下，亚太地区受到严重影响，尤其是印度。该地区的医疗实践继续适应新冠肺炎 (COVID-19) 的挑战。一方面，医疗保健专业人员正在应对这一流行病，另一方面，它确保对非新冠相关程序和住院治疗的干扰最小化。世界各地的医院和其他医疗机构被迫推迟手术等选择性手术。大多数非紧急治疗已被推迟。 COVID-19 大流行在多个方面影响了医疗保健服务，首先是中断了患者前往医疗保健机构的正常流动，给医疗保健资源造成压力和不堪重负，再到导致实施额外的保护措施和社会疏远，以及增加医疗资源的利用率。远程医疗和虚拟医疗。作为预防措施，肿瘤科采取了具体措施，减少门诊患者数量，减少不必要或选择性手术，并使患者退出住院服务。这对该地区放射性药物市场的增长产生了负面影响。此外，市场参与者也因供应链逆势和需求减少而受到疫情影响。特种制药领域，尤其是放射性制药，受到了 COVID-19 和放射性制药领域竞争的影响。即使在大流行之前，核医学的供应链就非常复杂，这取决于原材料的可用性、制造设施的运营和航空运输的可靠性。因此，上述因素对该地区的放射性药物市场产生了负面影响。

市场概况和动态

亚太地区放射性药物市场预计将从2021年的13.8459亿美元增长到2028年的26.6138亿美元；预计 2021 年至 2028 年复合年增长率为 9.8%。靶向 α 疗法 (TAT) 是用于局部和全身癌症治疗的最新且不断发展的技术。临床前研究和临床试验证明，α发射放射性核素可以杀死目标癌细胞，并且不会伤害健康细胞（选择性细胞毒性）。 211At、213Bi、225Ac 和 227Th 属于α发射放射性同位素，用于标记单克隆抗体等靶向载体；用α发射放射性核素标记的单克隆抗体正在成为一种有效的放射免疫疗法。短程放射性同位素（α粒子）用于治疗血液癌症患者。 α辐射适合杀死血管和淋巴系统中的孤立癌细胞，以及通过扰乱肿瘤毛细血管网络来靶向和杀死肿瘤毛细血管内皮细胞（EC）来消退肿瘤。 Radium-223 二氯化物 α 疗法是唯一获得批准的用于体内 α 发射放射性同位素癌症治疗的概念。放射性元素到达恶性组织后衰变，释放出破坏肿瘤的辐射，而不会对邻近的健康组织造成重大损害。 α 辐射非常局部化，并且最多可穿透 2–10 个细胞层。周围组织中的健康细胞可以在一定程度上从辐射造成的任何损伤中恢复过来。核成像使用寿命较长的伽马发射器，随着肿瘤随着时间的推移增加对结合物的吸收，血液可以被清除，从而提高对比度。核成像剂可以诊断肿瘤和器官。此外，人们对α放射免疫疗法认识的提高以及癌症治疗程序的疗法可用性的激增正在推动对核成像的需求。因此，在癌症治疗中首选使用 α 放射免疫疗法正在推动亚太地区放射性药物市场的增长。

关键细分市场

从类型来看，诊断核医学领域在2020年亚太地区放射性药物市场中占据最大份额。从应用领域来看，肿瘤学领域在2020年亚太地区放射性药物市场中占据了较大的市场份额。 2020 年。此外，2020 年，按最终用户计算，医院细分市场在亚太地区放射性药物市场中占有较大份额。

主要来源和上市公司

准备本亚太地区放射性药物市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司是Advanced Accelerator Applications；拜耳公司；布拉科成像公司；康德乐健康公司；锔; ECZACIBA？I MONROL 核产品有限公司；通用电气; Lantheus 医学影像公司；诺迪恩；和 NTP 无线电同位素。

购买报告的理由

了解亚太地区放射性药物市场格局，并确定最有可能保证丰厚回报的细分市场
了解亚太地区放射性药物市场不断变化的竞争格局，保持领先地位
通过识别最有可能销售的细分市场，有效规划亚太地区放射性药物市场的并购和合作交易
通过对各个细分市场表现的敏锐和全面的分析，帮助做出明智的业务决策形成亚太地区放射性药物市场
获取亚太地区各细分市场 2021-2028 年的市场收入预测。

亚太地区放射性药物市场细分

亚太地区放射性药物市场 -按类型

诊断核医学
- SPECT
- PET
治疗核医学
- α发射体
- β发射体
- 近距离放射治疗同位素

< p>亚太地区放射性药物市场 - 按应用

肿瘤学
心脏病学
神经学
其他

亚太地区放射性药物市场 - 按最终用户划分

医院
影像中心
学术和研究中心 ;
其他

亚太地区放射性药物市场 - 按国家/地区

亚太地区放射性药物市场 - 公司简介

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Radiopharmaceuticals Market – By Type

1.3.2 APAC Radiopharmaceuticals Market – By Application

1.3.3 APAC Radiopharmaceuticals Market – By End User

1.3.4 APAC Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2 Escalating Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Presence of Alternatives

5.3 Market Opportunities

5.3.1 Soaring Growth in Emerging Countries

5.4 Future Trends

5.4.1 Rising Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– APAC Analysis

6.1 APAC Radiopharmaceuticals Market Revenue Forecast and Analysis

7. APAC Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Radiopharmaceuticals Market – Country Analysis

10.1 APAC: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on APAC Radiopharmaceuticals Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Nordion

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 NTP RADIOISOTOPES

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Advanced Accelerator Applications

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of APAC: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Radiopharmaceuticals Market Segmentation

Figure 2. APAC Radiopharmaceuticals Market Segmentation, By Country

Figure 3. APAC Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. APAC Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. APAC Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. APAC SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. APAC Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. APAC Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

亚太地区放射性药物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（诊断核医学和治疗核医学）、应用（肿瘤学、心脏病学、神经学等）和最终用户（医院、影像中心、学术和医院）研究中心等）

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample